OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

HTML

Year: 2015
Type: article
Study design: Clinical Trial
Source: Transplantation
DOI: 10.1097/tp.0000000000000741
Authors: Ashley A. Vo, Jua Choi, Irene Kim, Sabrina Louie, Kristen Cisneros, Joseph Kahwaji, Mieko Toyoda, Shili Ge, Mark Haas, Dechu Puliyanda, Nancy Reinsmoen, Alice Peng, Rafael Villicana, Stanley C. Jordan
Institutions: Cedars-Sinai Medical Center, University of California, Los Angeles
Language: English

Topic: Drug-Induced Adverse Reactions
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: tocilizumab, IL-6 receptor, intravenous immunoglobulin, desensitization, kidney transplantation, donor-specific antibodies, antibody-mediated rejection, rituximab, Th17 cells, adverse events, renal function
SDG: Good health and well-being

Open Access status: closed

Funder: Cedars-Sinai Medical Center
OpenAlex ID: W412766306
FWCI: 9.066
Cites: 31
Cited by: 219
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms